13 research outputs found
Clinical efficacy of intermittent pressure augmentedāretrograde cerebral perfusion
ObjectiveDuring aortic surgery under hypothermic circulatory arrest, retrograde cerebral perfusion (RCP) is commonly used as a cerebroprotective method to extend the duration of circulatory arrest safely. Kitahori and colleagues described a novel protocol of RCP using intermittent pressure augmented (IPA)āRCP in 2005. The aim of the present study was to determine the clinical effectiveness of this novel protocol.MethodsA total of 20 consecutive patients undergoing total replacement of the aortic arch were assigned to a conventional RCP (nĀ =Ā 10) or an IPA-RCP group (nĀ =Ā 10). Cerebral perfusion was provided at a continuous venous pressure of 25 mm Hg in the conventional RCP, and venous pressure was intermittently provided at 20 mm Hg for 120 seconds and at 45 mm Hg for 30 seconds in the IPA-RCP group. The clinical outcomes were compared between the 2 groups. Regional cerebral oxygen saturation (rSO2) was measured using near infrared spectroscopy every 10 minutes from the beginning of RCP initiation. To represent the brain oxygen consumption, the decline ratio of rSO2 was calculated.ResultsThere was no surgical mortality or major neurologic complications in either group. The interval from the end of surgery to full wakefulness was significantly shorter in the IPA-RCP group (85 Ā± 64 minutes) than in the conventional RCP group (310 Ā± 282 minutes; PĀ <Ā .05). Although the initial rSO2 value did not show significant difference in both groups, the rSO2 with IPA-RCP was greater than that with conventional RCP from 10 to 70 minutes (PĀ <Ā .05). The decline ratio of rSO2 was lower in the IPA-RCP group than in the RCP perfusion group at all points (PĀ <Ā .05).ConclusionsIPA-RCP might provide more homogenous cerebral perfusion and a more effective oxygen supply to the brain with better clinical results than conventional RCP
Clinical Result of Epicardial Pulmonary Vein Isolation (LAVIE) by Cryoablation as Concomitant Cardiac Operation and Clinical Application of New Ablation Device (KIRC-119 Infrared Coagulator) to Treat Atrial Fibrillation
Total aortic arch replacement under intermittent pressure-augmented retrograde cerebral perfusion
Kitahori, Kawata, Takamoto et al. described the effectiveness of a novel protocol for retrograde cerebral perfusion that included intermittent pressure augmentation for brain protection in a canine model. Based on their report, we applied this novel technique clinically. Although the duration of circulatory arrest with retrograde cerebral perfusion was long, the patient recovered consciousness soon after the operation and had no neurological deficit. Near-infrared oximetry showed recovery of intracranial blood oxygen saturation every time the pressure was augmented
Early and Definitive Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor VĪ²2-Positive T Cells
We describe two cases of early toxic shock syndrome, caused by the superantigen
produced from methicillin-resistant Staphylococcus aureus and
diagnosed on the basis of an expansion of T-cell-receptor
VĪ²2-positive T cells. One case-patient showed atypical symptoms. Our
results indicate that diagnostic systems incorporating laboratory techniques are
essential for rapid, definitive diagnosis of toxic shock syndrome
Xenopericardial roll graft replacement for infectious pseudoaneurysms and graft infections of the aorta
Off-pump hemostasis for left ventricular rupture after myocardial infarction with HydrofitĀ® and SurgicelĀ®
Equine pericardial roll graft replacement of infected pseudoaneurysm of the ascending aorta
Abstract The standard procedure for treating infected aortic aneurysms is to resect the infected aorta, debridement of the surrounding tissue, in situ graft replacement, and omentopexy. However, the question of which graft material is optimal is still a matter of controversy. We recently treated a patient with an infected ascending aortic aneurysm. Because of previous abdominal surgery, the omentum was unavailable. The ascending aorta was replaced in situ with equine pericardial roll grafts. The patient is alive and well 29 months after the operation.</p